Measurement of the Performance and Safety of RTR+Membrane in Guided Tissue Regeneration (GTR) in Dental Surgical Procedures
NCT ID: NCT06467630
Last Updated: 2024-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
90 participants
OBSERVATIONAL
2024-02-09
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the GTR Procedure Alone and in Combination With Immediate OTM
NCT04896450
Guided Tissue Regeneration in the Healing of Through and Through Lesions
NCT03284736
Guided Tissue Regeneration With a Periodontal Dressing
NCT05756946
Role of GTR on Healing Outcome & Quality of Life in Combined Endo Perio Lesions With Communication
NCT06643663
Efficacy of Guided Tissue Regeneration in the Healing of Periapical Defects With Periodontal Communication Using CBCT
NCT03905590
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* post-extraction socket preservation,
* alveolar ridge augmentation,
* Guided Tissue Regeneration (GTR) during immediate implant placement.
Since it is a real-life evidence study in current practice, patients will be followed at their surgery and their follow-ups. Below are listed visits and type of data collected.
* V1 - Surgery: Demography, Medical history and concomitant treatments, Clinical/technical information (tooth extraction, surgery, membrane and grafting materials use), Clinical Exam, Photography, X-rays or Cone Beam Computed Tomography (CBCT)
* V2 - Early follow-up (including suture removal, if needed): Clinical Exam, Questionnaire, Photography
* V2bis - Early follow-up: Clinical Exam, Photography
* V3 - Late follow-up: Clinical Exam, Photography, X-rays or CBCT, Questionnaire
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Post-extraction socket preservation group
The 30 eligible patients are any male and female, adult patients with the following dental treatment to be done with the study device: Post-extraction socket preservation (not done concomitantly to implant placement).
Preserving alveolar bone volume after tooth extraction
* Visit 1: A periodontal or dental implant surgery is done aiming to preserve alveolar bone volume after extraction
* Visit 2 (10 days ± 4 days) - Early post-surgery follow-up
* V2bis (1 month +/- 1 week) - Early post-surgery follow-up
* Visit 3 (5 months ± 1 month) - Late post-surgery follow-up
Alveolar ridge augmentation group
The 30 eligible patients are any male and female, adult patients with the following dental treatment to be done with the study device: Alveolar ridge augmentation (not done concomitantly to implant placement).
Alveolar crest reconstruction
* Visit 1: A periodontal or dental implant surgery is done aiming to alveolar crest reconstruction
* Visit 2 (10 days ± 4 days) - Early post-surgery follow-up
* Visit 3 (5 months ± 1 month) - Late post-surgery follow-up
Guided Tissue Regeneration (GTR) during immediate implant placement group
The 30 eligible patients are any male and female, adult patients with the following dental treatment to be done with the study device: Guided Tissue Regeneration (GTR) during immediate implant placement
Covering bone defects during immediate implant placement.
* Visit 1: A periodontal or dental implant surgery is done aiming to cover bone defects during immediate implant placement.
* Visit 2 (10 days ± 4 days) - Early post-surgery follow-up
* Visit 3 (3 months ± 1 month) - Late post-surgery follow-up
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Preserving alveolar bone volume after tooth extraction
* Visit 1: A periodontal or dental implant surgery is done aiming to preserve alveolar bone volume after extraction
* Visit 2 (10 days ± 4 days) - Early post-surgery follow-up
* V2bis (1 month +/- 1 week) - Early post-surgery follow-up
* Visit 3 (5 months ± 1 month) - Late post-surgery follow-up
Alveolar crest reconstruction
* Visit 1: A periodontal or dental implant surgery is done aiming to alveolar crest reconstruction
* Visit 2 (10 days ± 4 days) - Early post-surgery follow-up
* Visit 3 (5 months ± 1 month) - Late post-surgery follow-up
Covering bone defects during immediate implant placement.
* Visit 1: A periodontal or dental implant surgery is done aiming to cover bone defects during immediate implant placement.
* Visit 2 (10 days ± 4 days) - Early post-surgery follow-up
* Visit 3 (3 months ± 1 month) - Late post-surgery follow-up
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with one of the 3 following dental treatments to be done with the study device: post-extraction socket preservation, alveolar ridge augmentation, or Guided Tissue Regeneration (GTR) during immediate implant placement.
* Patient affiliated or beneficiary of a social security system.
* Patient has signed his/her informed consent form.
Exclusion Criteria
* Active tissue infection at the implant site
* Several dental treatments done simultaneously in non-contiguous dental zones
* Heavy smoker (\>10 cigarettes / day)
* Patient receiving long-term corticosteroid therapy, anti-rejection drugs, bisphosphonates, head \& neck radiotherapy or chemotherapy
* Patient with chronic infections (such as osteomyelitis) at the surgical site
* Patient with poorly controlled metabolic disorders (such as diabetes, osteomalacia, thyroid disorders)
* Patient with an auto-immune disease
* Patient under tutelage, vulnerable person, person without liberty, or unable to complete questionnaire independently
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Septodont
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alain Hoornaert, DDS
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Nantes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital University of Nantes
Nantes, , France
Private dental practice office of Dr. Alain Hoornaert
Nantes, , France
Private dental practice office of Dr. Samer Saloum-Rouxel
Nantes, , France
Private dental practice office of Dr. Xavier Struillou
Nantes, , France
Private dental practice office of Dr. Edouard Lanoiselée
Nozay, , France
Private dental practice office of Dr. Aurélien Fruchet
Olonne-sur-Mer, , France
Private dental practice office of Dr. Hélène Le Hécho
Orée d'Anjou, , France
Private dental practice office of Dr. Nicolas Strube
Orvault, , France
Private dental practice office of Dr. Romain Besnier
Orvault, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Samer Saloum-Rouxel, DDS
Role: primary
Xavier Struillou, DDS
Role: primary
Edouard Lanoiselée, DDS
Role: primary
Aurélien Fruchet, DDS
Role: primary
Hélène Le Hécho, DDS
Role: primary
Nicolas Strube, DDS
Role: primary
Romain Besnier, DDS
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RTR+ 2023-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.